Exelixis
EXEL
#1645
Rank
C$13.80 B
Marketcap
$50.11
Share price
0.11%
Change (1 day)
61.81%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company